LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering MiR-361-3p to Augment PODXL Expression

Overview

Journal Reprod Sci

Publisher Springer

Specialty Reproductive Medicine

Date 2020 Nov 7

PMID 33159291

Citations 17

Authors

Huiping Yao

Rui Chen

Yongxiu Yang

Juan Jiang

Affiliations

Soon will be listed here.

Abstract

Ovarian cancer (OC) is a kind of common gynecological malignancy around the world. Mounting literatures have confirmed the implication of lncRNAs in the development of various cancers. Long non-coding RNA (LncRNA) BBOX1-AS1 has not been reported in most cancer types including OC. Presently, we aimed at exploring the function and regulatory mechanism of BBOX1-AS1 in OC. As a result, we demonstrated the extremely high BBOX1-AS1 expression in OC tissues and cells. BBOX1-AS1 silence inhibited OC progression by suppressing cell proliferation and promoting cell apoptosis. Importantly, BBOX1-AS1 was verified to bind to miR-361-3p, which presented a low expression trend in OC cells. Subsequently, PODXL was testified as the downstream target of miR-361-3p. Of note, BBOX1-AS1 positively regulated PODXL through their competition in binding with miR-361-3p. Furthermore, miR-361-3p inhibition facilitated the growth of BBOX1-AS1-deficient OC cells, while such facilitating effect was then counteracted in response to PODXL depletion. All the results above explained that BBOX1-AS1 was overexpressed in OC and that BBOX1-AS1 caused carcinogenic influences on OC cell growth via miR-361-3p/PODXL pathway, highlighting BBOX1-AS1 as a novel potential target for OC treatment.

Citing Articles

BBOX1-AS1 promotes gastric cardia adenocarcinoma progression via interaction with CtBP2 to facilitate the epithelial-mesenchymal transition process.

Zou W, Yin Q, Guo W, Dong Z, Guo Y Cancer Sci. 2024; 115(12):3875-3889.

PMID: 39318101 PMC: 11611761. DOI: 10.1111/cas.16350.

A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression.

Hu J, Liu J, Zhou S, Luo H Cancer Cell Int. 2023; 23(1):263.

PMID: 37925403 PMC: 10625699. DOI: 10.1186/s12935-023-03113-3.

The long non-coding RNA BBOX1 antisense RNA 1 is upregulated in polycystic ovary syndrome (PCOS) and suppresses the role of microRNA-19b in the proliferation of ovarian granulose cells : Short title: BBOX1 antisense RNA 1 in cell proliferation.

Zhou Z, Zhang Y, Tan C, Zhang J, Yi G, Wang B BMC Womens Health. 2023; 23(1):508.

PMID: 37735639 PMC: 10512487. DOI: 10.1186/s12905-023-02632-5.

Prognostic effect of lncRNA BBOX1-AS1 in malignancies: a meta-analysis.

Lin G, Wang Y, Deng L, Ye T Front Genet. 2023; 14:1234040.

PMID: 37636267 PMC: 10453800. DOI: 10.3389/fgene.2023.1234040.

Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1.

Wang Q, Li X, Zhou Y, Qin X, Wang L, Xiao M Transl Oncol. 2023; 36:101751.

PMID: 37544035 PMC: 10423889. DOI: 10.1016/j.tranon.2023.101751.

References

Banerjee S, Kaye S . New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential. Clin Cancer Res. 2013; 19(5):961-8. DOI: 10.1158/1078-0432.CCR-12-2243. View

Dai J, Wei R, Zhang P, Kong B . Overexpression of microRNA-195-5p reduces cisplatin resistance and angiogenesis in ovarian cancer by inhibiting the PSAT1-dependent GSK3β/β-catenin signaling pathway. J Transl Med. 2019; 17(1):190. PMC: 6551881. DOI: 10.1186/s12967-019-1932-1. View

Ma N, Li S, Zhang Q, Wang H, Qin H, Wang S . Long non-coding RNA GAS5 inhibits ovarian cancer cell proliferation via the control of microRNA-21 and SPRY2 expression. Exp Ther Med. 2018; 16(1):73-82. PMC: 5995084. DOI: 10.3892/etm.2018.6188. View

Lin N, Yao Z, Xu M, Chen J, Lu Y, Yuan L . Long noncoding RNA MALAT1 potentiates growth and inhibits senescence by antagonizing ABI3BP in gallbladder cancer cells. J Exp Clin Cancer Res. 2019; 38(1):244. PMC: 6555920. DOI: 10.1186/s13046-019-1237-5. View

Peng Y, Leng W, Duan S, Hong M . Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p. Biomed Pharmacother. 2019; 116:109027. DOI: 10.1016/j.biopha.2019.109027. View

Ye Y, Gu B, Wang Y, Shen S, Huang W . YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway. Cancer Biother Radiopharm. 2019; 34(8):519-528. DOI: 10.1089/cbr.2018.2745. View

Liu Y, Wang Y, Yao D, Cui D . LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis. Mol Med Rep. 2018; 17(6):8282-8288. PMC: 5984009. DOI: 10.3892/mmr.2018.8892. View

Tao F, Tian X, Lu M, Zhang Z . A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c. J Genet Genomics. 2018; 45(3):137-145. DOI: 10.1016/j.jgg.2018.03.001. View

Zhong Y, Wang J, Lv W, Xu J, Mei S, Shan A . LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis. J Cell Biochem. 2019; 120(10):17131-17141. DOI: 10.1002/jcb.28973. View

10.

He Z, Dang J, Song A, Cui X, Ma Z, Zhang Z . NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo. J Cell Physiol. 2019; 234(11):19582-19591. DOI: 10.1002/jcp.28557. View

11.

Ishikawa D, Takasu C, Kashihara H, Nishi M, Tokunaga T, Higashijima J . The Significance of MicroRNA-449a and Its Potential Target HDAC1 in Patients With Colorectal Cancer. Anticancer Res. 2019; 39(6):2855-2860. DOI: 10.21873/anticanres.13414. View

12.

Li L, Zhang Z, Yang Q, Ning M . Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis. Life Sci. 2019; 231:116528. DOI: 10.1016/j.lfs.2019.06.003. View

13.

Wang L, Yu M, Zhao S . lncRNA MEG3 modified epithelial-mesenchymal transition of ovarian cancer cells by sponging miR-219a-5p and regulating EGFR. J Cell Biochem. 2019; 120(10):17709-17722. DOI: 10.1002/jcb.29037. View

14.

Sun X, Huang T, Liu Z, Sun M, Luo S . LncRNA SNHG7 contributes to tumorigenesis and progression in breast cancer by interacting with miR-34a through EMT initiation and the Notch-1 pathway. Eur J Pharmacol. 2019; 856:172407. DOI: 10.1016/j.ejphar.2019.172407. View

15.

Chen L, Nan A, Zhang N, Jia Y, Li X, Ling Y . Circular RNA 100146 functions as an oncogene through direct binding to miR-361-3p and miR-615-5p in non-small cell lung cancer. Mol Cancer. 2019; 18(1):13. PMC: 6340182. DOI: 10.1186/s12943-019-0943-0. View

16.

Taniuchi K, Furihata M, Naganuma S, Sakaguchi M, Saibara T . Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients. PLoS One. 2019; 14(6):e0217920. PMC: 6550449. DOI: 10.1371/journal.pone.0217920. View

17.

Zhang J, Zhu Z, Wu H, Yu Z, Rong Z, Luo Z . PODXL, negatively regulated by KLF4, promotes the EMT and metastasis and serves as a novel prognostic indicator of gastric cancer. Gastric Cancer. 2018; 22(1):48-59. PMC: 6314994. DOI: 10.1007/s10120-018-0833-y. View

18.

Zhang J, Zhu Z, Sheng J, Yu Z, Yao B, Huang K . miR-509-3-5P inhibits the invasion and lymphatic metastasis by targeting PODXL and serves as a novel prognostic indicator for gastric cancer. Oncotarget. 2017; 8(21):34867-34883. PMC: 5471018. DOI: 10.18632/oncotarget.16802. View